Jinzheng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jinzheng Zhang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Jiajing Tang
Research Center for Nano‐Biomaterials Analytical and Testing Center Sichuan University Chengdu 610064 P. R. China
2 shared publications - Jieqiong Chen
Research Center for Nano‐Biomaterials Analytical and Testing Center Sichuan University Chengdu 610064 P. R. China
2 shared publications Qing Zhao
Research Center for Nano‐Biomaterials, Analytical & Testing Center Sichuan University Chengdu China
2 shared publications- Xiaoyu Lei
Research Center for Nano Biomaterials, Analytical & Testing Center, Sichuan University, Chengdu 610064, China
2 shared publications - Yi Zuo
Research Center for Nano-Biomaterials, Analytical and Testing Center, Sichuan University, Chengdu, China
2 shared publications - Yinglong Zhang
Research Center for Nano Biomaterials, Analytical & Testing Center, Sichuan University, Chengdu 610064, China
2 shared publications
Latest Publications
- 14 October 2025
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 143 (4)
Moisture‐Tolerant Polyurethane‐Based Bone Cement Containing Enoxacin for the Sex‐Specific Repair of Osteoporotic Defects
To address the challenges associated with bone cement curing in the presence of bleeding, a moisture‐tolerant polyurethane‐based cement was developed, demonstrating gender‐specific therapeutic efficacy when repairing osteoporotic bone defects. The synthesized cements (PHE‐1, PHE‐2, and PHE‐3) incorporated osteoinductive nano‐hydroxyapatite (20 wt%) and varying concentrations of enoxacin (EN, 1–3 wt%) as an osteoclast inhibitor. These formulations exhibited moderate curing temperatures (36.8°C–40.7°C), maintained mechanical stability in the presence of blood, and achieved 99% monomer conversion within 240 min via moisture‐triggered –NCO reactions. In vitro evaluations showed that PHE‐2 effectively inhibited osteoclastogenesis in RAW 264.7 cells while simultaneously promoting osteogenic differentiation in bone marrow‐derived mesenchymal stem cells. In vivo studies revealed more efficacious bone healing in ovariectomized rats compared to orchiectomized rats after 8 weeks of implantation. This difference was attributed to estrogen deficiency accelerating the degradation of the bone organic matrix, whereas androgen deficiency impaired biomineralization processes. Further mechanistic analysis indicated that gender‐specific differences in bone turnover result from the enhanced matrix degradation induced by estrogen deficiency. Notably, PHE‐2 effectively mitigated matrix‐related pathologies associated with ovariectomies. This study highlights the importance of gender‐specific approaches in managing osteoporotic bone defects and underscores the therapeutic potential of EN‐loaded polyurethane cement for treating osteoporotic defects.
- 14 October 2025
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 143 (4)
Moisture‐Tolerant Polyurethane‐Based Bone Cement Containing Enoxacin for the Sex‐Specific Repair of Osteoporotic Defects
To address the challenges associated with bone cement curing in the presence of bleeding, a moisture‐tolerant polyurethane‐based cement was developed, demonstrating gender‐specific therapeutic efficacy when repairing osteoporotic bone defects. The synthesized cements (PHE‐1, PHE‐2, and PHE‐3) incorporated osteoinductive nano‐hydroxyapatite (20 wt%) and varying concentrations of enoxacin (EN, 1–3 wt%) as an osteoclast inhibitor. These formulations exhibited moderate curing temperatures (36.8°C–40.7°C), maintained mechanical stability in the presence of blood, and achieved 99% monomer conversion within 240 min via moisture‐triggered –NCO reactions. In vitro evaluations showed that PHE‐2 effectively inhibited osteoclastogenesis in RAW 264.7 cells while simultaneously promoting osteogenic differentiation in bone marrow‐derived mesenchymal stem cells. In vivo studies revealed more efficacious bone healing in ovariectomized rats compared to orchiectomized rats after 8 weeks of implantation. This difference was attributed to estrogen deficiency accelerating the degradation of the bone organic matrix, whereas androgen deficiency impaired biomineralization processes. Further mechanistic analysis indicated that gender‐specific differences in bone turnover result from the enhanced matrix degradation induced by estrogen deficiency. Notably, PHE‐2 effectively mitigated matrix‐related pathologies associated with ovariectomies. This study highlights the importance of gender‐specific approaches in managing osteoporotic bone defects and underscores the therapeutic potential of EN‐loaded polyurethane cement for treating osteoporotic defects.
- 8 February 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (25)
Self‐Activating Phosphorus‐Rich Substrate Import Enzyme Catalytic Domains for Bone Regeneration
Enzymes play a key role in natural mineralization, but their function is disabling in bone metabolism when patients suffer severe degenerations like hypophosphatasia. To regulate bone homeostasis, a self‐activating phosphorus‐rich system is proposed on calcium glycerophosphate (CaGP) modified polyurethane (PU) fibrous substrate, wherein ample enzyme catalytic domains are imported with intestinal alkaline phosphatase (IALP) chelating and activating by calcium in situ that is testified by chemical potential evaluation. Therefore, Ca‐bonding IALP catalyzes organophosphate to phosphate locally to achieve a calcified symbiotic state, regulating mineralization and accelerating osteoinduction in vitro and in vivo. The self‐activating enzyme system promotes early osteogenic differentiation and angiogenesis, resulting in rapid healing of cranial defect with a “long‐tail” effect compared to an enzyme‐assisted system. Transcriptomic and metabolomic analyses demonstrate positive associations with neovascularization and calcium/phosphorus metabolism, specifically upregulated glycerophospholipids and calcium ions in favor of osteogenic differentiation under cytokine‐free conditions. These results provide a potential enzyme‐activating therapy in bone homeostasis and regeneration.
- 8 February 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (25)
Self‐Activating Phosphorus‐Rich Substrate Import Enzyme Catalytic Domains for Bone Regeneration
Enzymes play a key role in natural mineralization, but their function is disabling in bone metabolism when patients suffer severe degenerations like hypophosphatasia. To regulate bone homeostasis, a self‐activating phosphorus‐rich system is proposed on calcium glycerophosphate (CaGP) modified polyurethane (PU) fibrous substrate, wherein ample enzyme catalytic domains are imported with intestinal alkaline phosphatase (IALP) chelating and activating by calcium in situ that is testified by chemical potential evaluation. Therefore, Ca‐bonding IALP catalyzes organophosphate to phosphate locally to achieve a calcified symbiotic state, regulating mineralization and accelerating osteoinduction in vitro and in vivo. The self‐activating enzyme system promotes early osteogenic differentiation and angiogenesis, resulting in rapid healing of cranial defect with a “long‐tail” effect compared to an enzyme‐assisted system. Transcriptomic and metabolomic analyses demonstrate positive associations with neovascularization and calcium/phosphorus metabolism, specifically upregulated glycerophospholipids and calcium ions in favor of osteogenic differentiation under cytokine‐free conditions. These results provide a potential enzyme‐activating therapy in bone homeostasis and regeneration.